Somayeh Niknazar Selected Research

Somayeh Niknazar Research Topics

3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2018
3	Ischemia 01/2020 - 08/2013
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2021 - 09/2018
2	Epilepsy (Aura) 12/2020 - 01/2020
1	Hypothermia 11/2023
1	Inflammation (Inflammations) 11/2023
1	Sensorineural Hearing Loss 11/2023
1	Multiple Sclerosis 01/2022
1	Parkinson Disease (Parkinson's Disease) 01/2022
1	Tremor (Tremors) 01/2022
1	Parkinsonian Disorders (Parkinsonism) 01/2022
1	Contusions 01/2021
1	Hearing Loss (Hearing Impairment) 01/2021
1	Noise-Induced Hearing Loss (Acoustic Trauma) 01/2021
1	Seizures (Absence Seizure) 12/2020
1	Memory Disorders (Memory Loss) 01/2020
1	Brain Ischemia (Cerebral Ischemia) 06/2019
1	Cognitive Dysfunction 01/2018
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2018
1	Reperfusion Injury 01/2017
1	Renal Insufficiency (Renal Failure) 01/2017
1	Body Weight (Weight, Body) 01/2017
1	Hypoxia (Hypoxemia) 01/2015

4	Neuroprotective AgentsIBA 01/2021 - 01/2017
3	apelin-13 peptideIBA 01/2021 - 06/2019
2	Biomarkers (Surrogate Marker)IBA 11/2023 - 12/2020
2	ApelinIBA 01/2021 - 01/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 11/2023
1	NitrogenIBA 11/2023
1	Oxygen (Dioxygen)IBA 11/2023
1	Therapeutic UsesIBA 01/2022
1	NeuropeptidesIBA 01/2021
1	Phosphopyruvate Hydratase (Enolase)IBA 12/2020
1	Calcium-Binding ProteinsIBA 12/2020
1	carvacrolIBA 01/2020
1	AntioxidantsIBA 01/2020
1	Monoterpenes (Monoterpenoids)IBA 01/2020
1	ChloridesIBA 01/2018
1	BerberineIBA 01/2018
1	Erythropoietin FDA Link 01/2017
1	Gentamicins (Gentamicin)FDA LinkGeneric 01/2017
1	TOR Serine-Threonine KinasesIBA 08/2013
1	Superoxide DismutaseIBA 08/2013

3	Therapeutics 01/2022 - 09/2018
2	Low-Level Light Therapy (LLLT) 01/2022 - 01/2022
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 01/2015
1	Laser Therapy (Surgery, Laser) 01/2022
1	Laminectomy 01/2021
1	Stem Cell Transplantation 09/2018